RESUMEN
Our objective was to evaluate the lactational responses of dairy cows to methionine provided from 2 ruminally protected sources of methionine activity. Twenty-one Holstein dairy cows [11 primiparous (634 kg of body weight, 140 d in milk) and 10 second-parity (670 kg of body weight, 142 d in milk)] were assigned to a treatment sequence in 4 replicated 5 × 5 Latin squares plus 1 cow, with 14-d periods. Treatments were as follows: control; 7.5 or 15 g/d of a ruminally protected product of 2-hydoxy-4-methylthio-butyric acid (NTP-1401; Novus International Inc., St. Charles, MO); or 7.5 or 15 g/d of a ruminally protected dl-methionine product (Smartamine M; Adisseo, Alpharetta, GA). The diet was predicted to meet metabolizable protein and energy requirements. Diets contained 16.1% crude protein, and the control diet was predicted to be deficient in metabolizable methionine (1.85% of metabolizable protein) but sufficient in lysine (6.8% of metabolizable protein). Feed intake and milk yield were measured on d 11 to 14. Blood was collected on d 14. Dry matter intake, milk yield, energy-corrected milk, milk fat yield and percentage, and efficiencies of milk and energy-corrected milk yield were not affected by treatment. Milk protein percentage and milk protein yield increased linearly with supplementation, without differences between methionine sources or interactions between source and level. Linear regressions of milk protein percentage and milk protein yield against supplement amount within source led to slope ratios (NTP-1401:Smartamine M) of 95% for protein percentage and 84% for protein yield, with no differences between sources for increasing milk protein. Plasma methionine concentrations were increased linearly by methionine supplementation; the increase was greater for Smartamine M than for NTP-1401. Plasma d-methionine was increased only by Smartamine M. Plasma 2-hydoxy-4-methylthio-butyric acid was increased only by NTP-1401. Our data demonstrated that supplementation with these methionine sources can improve milk protein percentage and yield, and the 2 methionine sources did not differ in their effect on lactation performance or milk composition.
Asunto(s)
Bovinos/metabolismo , Metionina/farmacocinética , Rumen/metabolismo , Alimentación Animal/análisis , Animales , Disponibilidad Biológica , Dieta/veterinaria , Proteínas en la Dieta/administración & dosificación , Suplementos Dietéticos , Femenino , Lactancia/fisiología , Lisina/administración & dosificación , Metionina/administración & dosificación , Metionina/metabolismo , Leche/química , Leche/metabolismo , Proteínas de la Leche/análisis , Proteínas de la Leche/metabolismo , Necesidades Nutricionales , Paridad , EmbarazoRESUMEN
The objective of this study was to investigate the effect of feeding different levels of ruminally protected methionine and choline on the incidence of physiological and metabolic disorders, production, and some of the reproductive indices of Holstein dairy cows. Forty Holstein dairy cows in their first and second lactation were used from 4-week pre-partum through 20-week post-partum and randomly assigned to receive one of the following treatments: 18 g/day of rumen-protected methionine (RPM), 60 g/day of rumen-protected choline (RPC), 18 g/day of RPM + 60 g/day of RPC, and neither supplement (control). The treatments significantly affected services per conception and open days of lactating dairy cows (p < 0.05), but did not affect significantly on days to first oestrus and number of pregnant cows. RPM + RPC-fed cows had the lowest open days, days to first oestrus and services per conception compared with other groups. The effect of treatments was significant on the incidence of metabolic and physiological problems except for foot/leg problems. Cows fed RPM+RPC had the lowest health problems compared with other groups (p < 0.05). Results indicate that the supplementation of RPM and RPC can improve reproductive performance and health status of dairy cows.
Asunto(s)
Enfermedades de los Bovinos/prevención & control , Colina/farmacología , Metionina/farmacología , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Bovinos , Dieta/veterinaria , Femenino , Embarazo , Reproducción , RumenRESUMEN
Twenty Holstein dairy cows in their first and second lactation were used from 4-week prepartum through 20-week postpartum. The aim was to investigate the effect of feeding different levels of ruminally protected methionine and choline on health situation and reproductive indices of Holstein dairy cows. Cows were randomly assigned to receive one of the following treatments: 18 g day(-1) of rumen protected methionine (RPM), 60 g day(-1) of rumen protected choline (RPC), 18 g day(-1) of RPM + 60 g day(-1) of RPC and neither supplement (control). The treatments significantly affected services per conception and open days of lactating dairy cows, but did not significantly affect on days to first estrus and number of pregnant cows. RPM + RPC-fed cows had the lowest open days, days to first estrus and services per conception compared with other groups. Although no statistical differences were noted for any given health category, the overall incidence of health-related disorders was numerically lowest for cows fed RPM + RPC. Results indicate that the supplementation of RPM and RPC have been improved reproductive performance and health situation of dairy cows.
Asunto(s)
Colina , Industria Lechera , Suplementos Dietéticos , Estado de Salud , Metionina , Rumen/metabolismo , Alimentación Animal , Animales , Bovinos , Colina/administración & dosificación , Colina/metabolismo , Femenino , Lactancia , Metionina/administración & dosificación , Metionina/metabolismo , Embarazo , ReproducciónRESUMEN
BACKGROUND: Endothelial damage and dysfunction are commonplace in renal transplant recipients. Impaired endothelial function is an important contributor to cardiovascular diseases. We hypothesized that short-term black tea consumption may improve endothelium-dependent arterial dilation in kidney recipients. METHODS: Fifteen recipients were studied on an outpatient basis in a single, university-affiliated clinic. Inclusion criteria were stable and good allograft function. The main exclusion criteria were uncontrolled hypertension, smoking, alcohol consumption, coffee drinking, diabetes mellitus, and coronary artery disease, or a history of upper limb vascular manipulations. After overnight fasting, the brachial artery diameter (BAD) was measured at the end of diastole using an ultrasound machine before (basal BAD) and 1 minute after temporary ( approximately 3 minutes) external occlusion (posthyperemia BAD). Flow-mediated vasodilation (FMV) and percent of FMV (FMV%) were calculated by appropriate formula. FMV and FMV% were determined at baseline and 2 hours after consuming 0.5 L freshly brewed black tea. For control, the study was repeated for each patient the next day and FMV and FMV% were determined before and 2 hours after consuming 0.5 L of water. RESULTS: The men age of patients was 37.2 +/- 9.7 years (range, 25 to 50) with a male:female ratio of 3:2. Patients were 26.8 +/- 10.6 months postrenal transplantation. Black tea consumption significantly increased posthyperemia BAD, FMV, and FMV% (P<.05). However, water consumption did not alter the basal or posthyperemia BAD, FMV, or FMV% (P>.05). CONCLUSION: Based on our study, short-term consumption of black tea may improve endothelial function and endothelium-dependent arterial vasodilation in renal transplant recipients.